Liminatus Pharma, Inc. (LIMN)
0.244
+0.06
(+29.93%)
USD |
NASDAQ |
May 21, 16:00
0.23
-0.01
(-5.74%)
After-Hours: 19:31
Liminatus Pharma Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oruka Therapeutics, Inc. | -14.44M |
| MapLight Therapeutics, Inc. | 67.01M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | -127.96M |
| Insight Molecular Diagnostics, Inc. | -0.613M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.015M |
| Cash from Financing (Quarterly) | 3.585M |
| Free Cash Flow | -11.99M |
| Free Cash Flow Per Share (Quarterly) | -0.056 |
| Free Cash Flow to Equity (Quarterly) | -2.015M |
| Free Cash Flow to Firm (Quarterly) | -1.997M |
| Free Cash Flow Yield | -173.4% |